BioCentury | Apr 15, 2013
Company News

Kendle, GMI Gesellschaft fur Angewandte Mathematik und Informatik mbH deal

...Kendle will provide about $8.35 million and 190,000 shares of its common stock to GMI. Kendle International Inc....
BioCentury | Apr 15, 2013
Company News

Techniclone management update

...Pharm.D., as VP of clinical affairs; formerly director of clinical research immunology and oncology at Kendle International Inc. WIR...
BioCentury | May 9, 2011
Company News

INC Research, Kendle deal

...INC Research will acquire fellow CRO Kendle for $15.25 per share, or about $232 million in...
...per share, or about $232 million in cash. The price is a 61% premium to Kendle's...
...Kendle shareholder approval, is expected to close next quarter. INC Research Inc. , Raleigh, N.C. Kendle International Inc....
BioCentury | Aug 21, 2006
Company News

Charles River, Kendle deal

...million in cash (see BioCentury, May 15). Charles River Laboratories International Inc. (CRL), Wilmington, Mass. Kendle International Inc....
BioCentury | May 15, 2006
Finance

EPS watch

...associated with the research tool supplier's selling of its Phase II-IV Clinical Services business to Kendle...
BioCentury | May 15, 2006
Company News

Charles River, Kendle deal

...preclinical services and clinical Phase I businesses. Charles River Laboratories International Inc. (CRL), Wilmington, Mass. Kendle International Inc....
BioCentury | May 11, 2006
Financial News

Charles River misses Street, cuts guidance

...CRL also restructured and said it will sell its Phase II-IV clinical services business to Kendle...
BioCentury | Oct 8, 2001
Company News

Kendle board of directors update

Kendle International Inc. (KNDL), Cincinnati, Ohio Business: Supply/Service Appointed: Robert Simpson, former group president and director of West Pharmaceutical Services Inc. ; he replaces Charles Sanders, who retired WIR Staff...
BioCentury | May 30, 2000
Company News

Kendle supply/service news

...million in the first quarter ended March 31, when it had $24.5 million in cash. Kendle International Inc....
BioCentury | Apr 17, 2000
Company News

Kendle, Synermedica Pty. Ltd. deal

...KNDL acquired CRO Synermedica for cash and stock. Kendle International Inc. (KNDL), Cincinnati, Ohio Synermedica Pty. Ltd...
Items per page:
1 - 10 of 25
BioCentury | Apr 15, 2013
Company News

Kendle, GMI Gesellschaft fur Angewandte Mathematik und Informatik mbH deal

...Kendle will provide about $8.35 million and 190,000 shares of its common stock to GMI. Kendle International Inc....
BioCentury | Apr 15, 2013
Company News

Techniclone management update

...Pharm.D., as VP of clinical affairs; formerly director of clinical research immunology and oncology at Kendle International Inc. WIR...
BioCentury | May 9, 2011
Company News

INC Research, Kendle deal

...INC Research will acquire fellow CRO Kendle for $15.25 per share, or about $232 million in...
...per share, or about $232 million in cash. The price is a 61% premium to Kendle's...
...Kendle shareholder approval, is expected to close next quarter. INC Research Inc. , Raleigh, N.C. Kendle International Inc....
BioCentury | Aug 21, 2006
Company News

Charles River, Kendle deal

...million in cash (see BioCentury, May 15). Charles River Laboratories International Inc. (CRL), Wilmington, Mass. Kendle International Inc....
BioCentury | May 15, 2006
Finance

EPS watch

...associated with the research tool supplier's selling of its Phase II-IV Clinical Services business to Kendle...
BioCentury | May 15, 2006
Company News

Charles River, Kendle deal

...preclinical services and clinical Phase I businesses. Charles River Laboratories International Inc. (CRL), Wilmington, Mass. Kendle International Inc....
BioCentury | May 11, 2006
Financial News

Charles River misses Street, cuts guidance

...CRL also restructured and said it will sell its Phase II-IV clinical services business to Kendle...
BioCentury | Oct 8, 2001
Company News

Kendle board of directors update

Kendle International Inc. (KNDL), Cincinnati, Ohio Business: Supply/Service Appointed: Robert Simpson, former group president and director of West Pharmaceutical Services Inc. ; he replaces Charles Sanders, who retired WIR Staff...
BioCentury | May 30, 2000
Company News

Kendle supply/service news

...million in the first quarter ended March 31, when it had $24.5 million in cash. Kendle International Inc....
BioCentury | Apr 17, 2000
Company News

Kendle, Synermedica Pty. Ltd. deal

...KNDL acquired CRO Synermedica for cash and stock. Kendle International Inc. (KNDL), Cincinnati, Ohio Synermedica Pty. Ltd...
Items per page:
1 - 10 of 25